Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation

Systemic Lupus Erythematosus Clinical Trial

— CO LUPUS  

Official title:

Cohort Follow-up of Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation at the CHRU of Brest

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04320680
• Other study ID #: 29BRC20.0073
• Status: Recruiting
• Phase: N/A
• Start date: October 13, 2020
• Est. completion date: May 13, 2025

Study information

• Verified date: January 2022
• Source: University Hospital, Brest
• Contact: sandrine jousse joulin, MD
• Phone: +33 2 98 34 72 68
• Email: sandrine.jousse-oulin[@]chu-brest.fr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Diagnosis and follow up of a lupus cohort in a multidisciplinary consultation in Brest ( France)

Description:

all patients coming to the LUPUS multidisciplinary consultation in brest ( France) will have a clinical examination, a biological and immunogical blood samples, cutaneous biopsies or renal biospies if necessary, an ultrasonographic articular and salivary glandular examination if needed. In case of articular involvement, some Xrays ( hands and feet) will be done at the inclusion and during the follow up each year during 5 years .

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 150
• Est. completion date: May 13, 2025
• Est. primary completion date: May 13, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• women or men, more than 18 years old, coming to the multidisciplinary consultation in brest ( France).

• With written consentment

Exclusion Criteria:

• patients less than 18 years old

• refusing to participate

• Under legal protection

Related Conditions & MeSH terms

• Lupus Erythematosus, Systemic
• Systemic Lupus Erythematosus

Intervention

Other:
• description of a lupus patient cohort
description of a lupus patient cohort

Locations

Country	Name	City	State
France	CHRU de Brest	Brest

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cohort lupus: epidemiologic lupus study about diagnosis and follow up	epidemiologic lupus study in collecting data ( description of the population, biologic and immunologic data collection, data of articular damges with xrays datas) about Diagnosis and follow up of a cohort lupus in a multidisciplibnary consultation in brest hospital ( France).	five years